Laurion Capital Management LP Roivant Sciences Ltd. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$10.36 - $11.74 $138,792 - $157,280
13,397 New
13,397 $141,000
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $1.54 Million - $2.12 Million
183,239 Added 10.76%
1,885,901 $21.2 Million
Q2 2023

Aug 14, 2023
BUY
$7.09 - $10.08 $4.68 Million - $6.65 Million
660,041 Added 63.31%
1,702,662 $17.2 Million
Q1 2023

May 15, 2023
BUY
$6.92 - $9.98 $7.21 Million - $10.4 Million
1,042,621 New
1,042,621 $7.69 Million

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email